Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Brigham and Women's Hospital
Massachusetts General Hospital
Novartis Pharmaceuticals
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
University of California, Los Angeles
University of Utah
Information provided by (Responsible Party):
Patrick Y. Wen, MD, Dana-Farber/Brigham and Women's Cancer Center
ClinicalTrials.gov Identifier:
NCT01339052
First received: April 18, 2011
Last updated: January 18, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)